James B. Weissman
2012
In 2012, James B. Weissman earned a total compensation of $539.1K as Chief Business Officer at Dicerna Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $44,250 |
|---|---|
| Option Awards | $78,325 |
| Salary | $295,000 |
| Other | $121,476 |
| Total | $539,051 |
Weissman received $295K in salary, accounting for 55% of the total pay in 2012.
Weissman also received $44.3K in non-equity incentive plan, $78.3K in option awards and $121.5K in other compensation.
Rankings
In 2012, James B. Weissman's compensation ranked 8,529th out of 11,487 executives tracked by ExecPay. In other words, Weissman earned more than 25.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,529 out of 11,487 | 26th |
Division Manufacturing | 3,097 out of 4,253 | 27th |
Major group Chemicals And Allied Products | 827 out of 1,198 | 31st |
Industry group Drugs | 602 out of 920 | 35th |
Industry Pharmaceutical Preparations | 472 out of 700 | 33rd |
Source: SEC filing on April 30, 2014.
Weissman's colleagues
We found two more compensation records of executives who worked with James B. Weissman at Dicerna Pharmaceuticals in 2012.